A significant advance in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant protector protein is frequently lost in several forms of cancer, resulting https://allkindsofsocial.com/story7358105/vhh-fragments-revive-tumor-suppressor-p53-the-potential-hope-for-tumor-treatment